Strict
limits on access to antiviral medication for Covid-19 have prompted some New Zealanders to try importing their own supplies.
Last year 1000 tablets were stopped at the border, and most were destroyed by Medsafe after those bringing them breached import requirements.
The two oral
antiviral medicines available in New Zealand to treat Covid-19 in the community are Paxlovid (nirmatrelvir with ritonavir) and molnupiravir.
To be eligible, people must
either have symptoms and test positive, or have symptoms and be a household contact of a case, plus they must also
meet other criteria relating to age and medical conditions.
The largest was a consignment of 480 molnupiravir tablets.
“All have been destroyed, except the most recent import which is still within its holding period to give the recipient an opportunity to respond.”
Fitzgerald said imports of unapproved medicine may be counterfeit, and there could be risks in terms of its effectiveness and quality.
The seven interceptions of paxlovid and molnupiravir have been tiny compared with
more than 900 attempted personal imports of ivermectin referred to Medsafe last year.